单疱病毒性角膜炎是严重的常见传染性眼病之一,常易复发,迄今尚无肯定的特效疗法。自碘苷应用以来,对本病疗效较满意,但仍存在某些问题,如耐药株与对角膜的毒性作用等。70年代以来,国外文献有用外源性干扰素治疗单疱病毒性角膜炎的报告。我们采用人(脐血)白细胞干扰素治疗单疱病毒性角膜炎25例(30眼)取得初步疗效。并对12例进行了治疗前后泪液中免疫球蛋白的测定。初步分析报道如下: Herpes simplex virus keratitis is one of the most common contagious ocular diseases, often relapse, so far there is no sure cure. Since the application of iodine, the effect of this disease is more satisfactory, but there are still some problems, such as drug-resistant strains and the role of corneal toxicity. Since the 1970s, foreign literature useful exogenous interferon treatment of herpes simplex virus keratitis report. We used human (cord blood) leukocyte interferon in the treatment of herpes simplex virus keratitis in 25 cases (30 eyes) to obtain the initial effect. And in 12 cases before and after treatment of immunoglobulin in the determination of tear. Preliminary analysis reported as follows: